Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

PGE2 signaling through the EP4 receptor on fibroblasts upregulates RANKL and stimulates osteolysis.

Tsutsumi R, Xie C, Wei X, Zhang M, Zhang X, Flick LM, Schwarz EM, O'Keefe RJ.

J Bone Miner Res. 2009 Oct;24(10):1753-62. doi: 10.1359/jbmr.090412.

2.

Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors.

Kawahara K, Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y.

Biochim Biophys Acta. 2015 Apr;1851(4):414-21. doi: 10.1016/j.bbalip.2014.07.008. Epub 2014 Jul 17. Review.

PMID:
25038274
3.

[Role of EP4 receptor in bone resorption induced by PGE].

Miyaura C.

Nihon Yakurigaku Zasshi. 2001 Apr;117(4):293-7. Review. Japanese.

PMID:
11338379
4.

Novel prostaglandin receptor modulators--part II: EP receptor modulators; a patent review (2002 - 2012).

Flesch D, Merk D, Lamers C, Schubert-Zsilavecz M.

Expert Opin Ther Pat. 2013 Feb;23(2):233-67. doi: 10.1517/13543776.2013.744822. Epub 2013 Jan 4. Review.

PMID:
23289354
5.

Prostaglandin E(2) receptors in bone formation.

Li M, Thompson DD, Paralkar VM.

Int Orthop. 2007 Dec;31(6):767-72. Epub 2007 Jun 26. Review.

6.

The role of the EP receptors for prostaglandin E2 in skin and skin cancer.

Rundhaug JE, Simper MS, Surh I, Fischer SM.

Cancer Metastasis Rev. 2011 Dec;30(3-4):465-80. doi: 10.1007/s10555-011-9317-9. Review.

7.

Current research in the pathogenesis of aseptic implant loosening associated with particulate wear debris.

Jiang Y, Jia T, Wooley PH, Yang SY.

Acta Orthop Belg. 2013 Feb;79(1):1-9. Review.

PMID:
23547507
8.

E-type prostanoid receptor 4 (EP4) in disease and therapy.

Konya V, Marsche G, Schuligoi R, Heinemann A.

Pharmacol Ther. 2013 Jun;138(3):485-502. doi: 10.1016/j.pharmthera.2013.03.006. Epub 2013 Mar 21. Review.

9.

Prostaglandins and prostaglandin receptor antagonism in migraine.

Antonova M.

Dan Med J. 2013 May;60(5):B4635. Review.

PMID:
23673269
10.

Role of PGE2 in asthma and nonasthmatic eosinophilic bronchitis.

Sastre B, del Pozo V.

Mediators Inflamm. 2012;2012:645383. doi: 10.1155/2012/645383. Epub 2012 Mar 19. Review.

11.

Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy.

Pang L, Cai Y, Tang EH, Irwin MG, Ma H, Xia Z.

J Diabetes Res. 2016;2016:1324347. doi: 10.1155/2016/1324347. Epub 2016 Apr 13. Review.

12.

Therapeutic targets in prostaglandin E2 signaling for neurologic disease.

Cimino PJ, Keene CD, Breyer RM, Montine KS, Montine TJ.

Curr Med Chem. 2008;15(19):1863-9. Review.

13.

Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.

Dey I, Lejeune M, Chadee K.

Br J Pharmacol. 2006 Nov;149(6):611-23. Epub 2006 Oct 2. Review.

14.

The role of prostaglandin E2 in human vascular inflammation.

Gomez I, Foudi N, Longrois D, Norel X.

Prostaglandins Leukot Essent Fatty Acids. 2013 Aug;89(2-3):55-63. doi: 10.1016/j.plefa.2013.04.004. Epub 2013 Jun 4. Review.

PMID:
23756023
15.

Roles of prostaglandin receptors in female reproduction.

Sugimoto Y, Inazumi T, Tsuchiya S.

J Biochem. 2015 Feb;157(2):73-80. doi: 10.1093/jb/mvu081. Epub 2014 Dec 4. Review.

PMID:
25480981
16.

The multiple faces of prostaglandin E2 G-protein coupled receptor signaling during the dendritic cell life cycle.

De Keijzer S, Meddens MB, Torensma R, Cambi A.

Int J Mol Sci. 2013 Mar 25;14(4):6542-55. doi: 10.3390/ijms14046542. Review.

17.

Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss.

Crotti TN, Dharmapatni AA, Alias E, Haynes DR.

J Immunol Res. 2015;2015:281287. doi: 10.1155/2015/281287. Epub 2015 May 3. Review.

18.

Prostaglandin EP4 antagonists.

Borriello M, Stasi LP.

Pharm Pat Anal. 2013 May;2(3):387-97. doi: 10.4155/ppa.13.15. Review.

PMID:
24237064
Items per page

Supplemental Content

Write to the Help Desk